Allysta

Allysta is a biopharmaceutical company that researches and develops peptide therapeutics for the treatment of nonalcoholic steatohepatitis. Read more

Allysta

Allysta is a biopharmaceutical company that researches and develops peptide therapeutics for the treatment of nonalcoholic steatohepatitis. Read more

Henry Hsu's photo - CEO of Allysta

CEO

Henry Hsu

CEO Approval Rating

90/100

Founded:

2014

Status:

PrivateIndependent Company

ALLYSTA TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Madrigal Pharmaceuticals is one of Allysta's top rivals. Madrigal Pharmaceuticals is a Public company that was founded in 2011 in West Conshohocken, Pennsylvania. Like Allysta, Madrigal Pharmaceuticals also works within the Pharmaceuticals industry. Compared to Allysta, Madrigal Pharmaceuticals has 9 more employees.

Metacrine is seen as one of Allysta's biggest rivals. Metacrine was founded in 2014 in San Diego, California. Like Allysta, Metacrine also competes in the Biotechnology sector. Metacrine generates $450K more revenue than Allysta.

89bio is one of Allysta's top competitors. 89bio was founded in 2018, and its headquarters is in San Francisco, California. Like Allysta, 89bio also competes in the Pharmaceuticals space. 89bio has 1 fewer employees than Allysta.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is $ < 1M a good estimate for Allysta's revenue?

Allysta Acquisitions

No recent acquisitions found related to Allysta

Allysta Funding History

$20M

Since Allysta was founded in 2014, it has participated in 2 rounds of funding. In total Allysta has raised $20.0M. Allysta's last funding round was on Dec 2019 for a total of $5.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series A
Dec 2019
$5M

Morningside Venture Investments Limited

Series A
Apr 2019
$15M

Since Allysta was founded in 2014, it has participated in 2 rounds of funding. In total Allysta has raised $20.0M. Allysta's last funding round was on Dec 2019 for a total of $5.0M

Allysta Investments

No recent investments found related to Allysta

Allysta News

Allysta Press Releases

Social Media

Allysta Headquarters

400 Concar Drive

San Mateo, California94402

Driving Directions »

Trending Companies

Allysta Summary

ABOUT

Overview

Allysta is a biopharmaceutical company that researches and develops peptide therapeutics for the treatment of nonalcoholic steatohepatitis. Allysta was founded in 2014. Allysta's headquarters is located in San Mateo, California, USA 94402. It has rais...

CEO

Allysta's CEO, Henry Hsu, currently has an approval rating of 90%. Allysta's primary competitors are Madrigal Pharmaceuticals, Metacrine & 89bio.

Website

allysta.com

Frequently Asked Questions about Allysta

  1. When was Allysta founded?

    Allysta was founded in 2014
  2. Who is Allysta's CEO?

    Allysta's CEO is Henry Hsu
  3. How much revenue does Allysta generate?

    Allysta generates $ < 1M in revenue
  4. How much funding does Allysta have?

    Allysta has historically raised $20M in funding
  1. Where is Allysta's headquarters?

    Allysta's headquarters is in San Mateo California, USA
  2. How many employees does Allysta have?

    Allysta has 20 employees
  3. What sector does Allysta operate in?

    Allysta is in Pharmaceuticals, Biotechnology
  4. Who are Allysta's competitors?

    Allysta's top competitors are Madrigal Pharmaceuticals, Metacrine, 89bio